Administration of recombinant IL-2 augments the level of serum IgM in an IL-2 deficient patient
β Scribed by S. Doi; O. Saiki; T. Hara; T. Sugita; K. Ha-Kawa; T. Tanaka; H. Hara; S. Negoro; H. Yabuuchi; S. Kishimoto
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 481 KB
- Volume
- 148
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
β¦ Synopsis
A patient with ataxia telangiectasia was treated with recombinant interleukin-2 (rIL-2) and the resulting immunological effects evaluated. The patient lacked IL-2 production, and immnnoglobulin synthesis was also impaired. Treatment with IL-2 selectively increased serum IgM without any significant side effects. Therapy also restored B-cell function in vitro, IgM production as well as the proliferative response to Staphylococcus aureus strain Cowan I. These results suggest that IL-2 treatment may correct both T-cell and B-cell defects.
π SIMILAR VOLUMES